Page last updated: 2024-10-22

amifostine anhydrous and Chronic Lung Injury

amifostine anhydrous has been researched along with Chronic Lung Injury in 2 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research Excerpts

ExcerptRelevanceReference
"Pulmonary injury is more common in patients undergoing radiation therapy for lungs and other thoracic malignancies."2.55Pulmonary injury associated with radiation therapy - Assessment, complications and therapeutic targets. ( Chandrasekharan, G; Rajan Radha, R, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kannan, GM1
Kumar, P1
Bhaskar, AS1
Pathak, U1
Kumar, D1
Nagar, DP1
Pant, SC1
Ganesan, K1
Rajan Radha, R1
Chandrasekharan, G1

Reviews

1 review available for amifostine anhydrous and Chronic Lung Injury

ArticleYear
Pulmonary injury associated with radiation therapy - Assessment, complications and therapeutic targets.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 89

    Topics: Amifostine; Animals; Humans; Lung; Lung Injury; Radiation-Protective Agents; Radiotherapy

2017

Other Studies

1 other study available for amifostine anhydrous and Chronic Lung Injury

ArticleYear
Prophylactic efficacy of S-2(2-aminoethylamino)ethyl phenyl sulfide (DRDE-07) against sulfur mustard induced lung toxicity in mice.
    Drug and chemical toxicology, 2016, Volume: 39, Issue:2

    Topics: Administration, Cutaneous; Administration, Oral; Amifostine; Animals; Bronchoalveolar Lavage Fluid;

2016